Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
N., Purdy, J., Zheng, I., Pan, C
Jr., et al
GLP-1 receptor agonists are now considered one of the most effective medical treatments for obesity and type 2 diabetes
An oral product avoids injection-site pain, bruising and the low risk of anaphylaxis
This was due to our decision to apply L1 regulation in order to obtain the simplest model for the purpose of helping clinicians determine which of their patients with T2D would most likely benefit from adding GLP-1 M as the second-line medication
Within a year of stopping their original medication: 27% switched to another obesity medication 20% restarted their original drug 14% continued treatment through lifestyle interventions, such as visits with dietitians or exercise specialists fewer than 1% underwent bariatric surgery
US$ 21.11
US$ 20.80
US$ 22.35
US$ 24.42
US$ 26.50
US$ 25.90
US$ 28.26
